Neutral
Study: UTI bacteria resist three common oral antibiotics
A new study by Hackensack Meridian CDI and Quest Diagnostics, published in Nature Communications, reveals that a common bacterial strain, Klebsiella p...
DGX
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (2)
Neutral (6)
Bearish (0)
Latest DGX News
Neutral
Neutral
Quest Diagnostics sets July 23 call for second-quarter results
Quest Diagnostics (NYSE: DGX) will report its second-quarter 2026 financial results on Thursday, July 23, 2026, before the market opens. A conference ...
Quest Diagnostics to Release Second Quarter Financial Results on July 23, 2026
Quest Diagnostics (NYSE: DGX) announced it will report its second-quarter 2026 financial results on Thursday, July 23, 2026, before the market opens. ...
Bullish
Quest Diagnostics Stock (US74834L1008): 2025 Responsibility Report Puts Healthcare Access and Sustainability in Focus
Quest Diagnostics released its 2025 Corporate Responsibility Report, highlighting expanded access to lab testing, improved employee engagement, and en...
Neutral
Quest Diagnostics Unveils Achievements in Healthcare Access, Employee Engagement and Environmental Sustainability in 2025 Corporate Responsibility Report
Quest Diagnostics released its 2025 Corporate Responsibility Report, highlighting over $21 million in discounted lab tests, improved workforce retenti...
Bullish
Quest Diagnostics Unveils Achievements in Healthcare Access, Employee Engagement and Environmental Sustainability in 2025 Corporate Responsibility Report
Quest Diagnostics released its 2025 Corporate Responsibility Report, highlighting significant achievements in healthcare access, employee engagement, ...
Neutral
Quest Diagnostics Stock (US74834L1008): Analyst Actions Shape Monday Focus After Quiet Newsflow
Quest Diagnostics shares are trading steadily on the NYSE, with current analyst ratings and valuation metrics taking center stage for investors due to...
Neutral
Affiliate sale notice — DGX (DGX) to sell 10,000 shares
An affiliate of Quest Diagnostics (DGX) has filed a Form 144 to sell 10,000 common shares for $2,125,200.00, with the sale reported on March 2, 2026. ...
Research DGX on:
Ad Space